Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021

SELL
$42.51 - $63.78 $18,151 - $27,234
-427 Closed
0 $0
Q2 2020

Aug 04, 2020

BUY
$46.85 - $61.05 $19,958 - $26,007
426 Added 42600.0%
427 $25,000
Q2 2020

Jul 27, 2020

SELL
$46.85 - $61.05 $19,958 - $26,007
-426 Reduced 99.77%
1 $25,000
Q1 2020

Apr 24, 2020

BUY
$41.6 - $63.4 $17,763 - $27,071
427 New
427 $20,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Jacobi Capital Management LLC Portfolio

Follow Jacobi Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.